Literature DB >> 3852361

The prevalence of hot flash and associated variables among perimenopausal women.

B M Feldman, A Voda, E Gronseth.   

Abstract

A telephone survey of a random sample of 594 perimenopausal women was done to study the prevalence of hot flashes, use of estrogen, age of menopause onset, and, among those subjects experiencing hot flashes, the frequency of occurrence and number of years of hot flashes. The prevalence of hot flashes was 88%. Surgical menopause women had a prevalence rate of 92% and had the highest estrogen utilization rate. The median age of onset for natural menopause women was 49 years. The frequency of occurrence and number of years of hot flash experience was variable across all groups.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3852361     DOI: 10.1002/nur.4770080308

Source DB:  PubMed          Journal:  Res Nurs Health        ISSN: 0160-6891            Impact factor:   2.228


  20 in total

1.  A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients.

Authors:  Haeseong Park; Gwendolyn L Parker; Cecelia H Boardman; Monica M Morris; Thomas J Smith
Journal:  Support Care Cancer       Date:  2011-01-27       Impact factor: 3.603

Review 2.  Menopausal hot flashes: mechanisms, endocrinology, treatment.

Authors:  Robert R Freedman
Journal:  J Steroid Biochem Mol Biol       Date:  2013-09-04       Impact factor: 4.292

3.  A Comprehensive Method To Quantify Adaptations by Male and Female Mice With Hot Flashes Induced by the Neurokinin B Receptor Agonist Senktide.

Authors:  Ashley A Krull; Sarah A Larsen; Donald K Clifton; Genevieve Neal-Perry; Robert A Steiner
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

4.  Initiation and discontinuation of hormone therapy for menopausal symptoms: results from a community sample.

Authors:  Hayden B Bosworth; Lori A Bastian; Steven C Grambow; Colleen M McBride; Celette Sugg Skinner; Laura Fish; Barbara K Rimer; Ilene C Siegler
Journal:  J Behav Med       Date:  2005-02

Review 5.  Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms.

Authors:  David F Archer
Journal:  Drugs Aging       Date:  2010-07-01       Impact factor: 3.923

Review 6.  Non-hormonal treatment strategies for vasomotor symptoms: a critical review.

Authors:  Elise Hall; Benicio N Frey; Claudio N Soares
Journal:  Drugs       Date:  2011-02-12       Impact factor: 9.546

7.  Depression, quality of life, work productivity, resource use, and costs among women experiencing menopause and hot flashes: a cross-sectional study.

Authors:  Marco Dacosta Dibonaventura; Jan-Samuel Wagner; Jose Alvir; Jennifer Whiteley
Journal:  Prim Care Companion CNS Disord       Date:  2012-11-01

8.  Provider attributes associated with hormone therapy prescribing frequency.

Authors:  Leslie Spangler; Susan D Reed; Larissa Nekhyludov; Louis C Grothaus; Andrea Z LaCroix; Katherine M Newton
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

9.  Levetiracetam for the treatment of hot flashes: a phase II study.

Authors:  Susan Thompson; Aditya Bardia; Angelina Tan; Debra L Barton; Lisa Kottschade; Jeff A Sloan; Brad Christensen; DeAnne Smith; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2007-06-28       Impact factor: 3.603

10.  Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis.

Authors:  Mary C Politi; Mark D Schleinitz; Nananda F Col
Journal:  J Gen Intern Med       Date:  2008-06-03       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.